Molecular Imaging: Page 75

Positron emission mammo shows prowess in cancer

By Wayne Forrest

Positron emission mammography (PEM) can detect almost all breast cancer index lesions located within its scanning range without limitations due to tumor size, grade, or histological subtype, according to a Dutch study presented at RSNA 2015 in Chicago.

December 13, 2015

EANM casts doubt on new hybrid imaging society

By Frances Rylands-Monk

Concerns have been raised by the president of the European Association of Nuclear Medicine (EANM), Dr. Arturo Chiti, about the risk of duplicating efforts in the emerging field of hybrid imaging, after the recent announcement of the formation of a new hybrid imaging society.

December 13, 2015

Beam-on PET tracks proton dose in real-time

By Tami Freeman, PhD

Exploiting the superior dose deposition of particle therapy for clinical benefit necessitates an accurate technique for verifying dose delivery. Because the treatment beam stops inside the patient, such monitoring requires detection of secondary radiation created when the incident beam interacts with the tissue, Dutch researchers found.

November 25, 2015

BIR approves Piramal PET reader training course

By AuntMinnieEurope.com staff writers

The British Institute of Radiology (BIR) has endorsed radiopharmaceutical firm Piramal Imaging's PET reader training course to help detect beta-amyloid plaques in patients with cognitive impairment.

November 24, 2015

ESR unveils plan for new hybrid imaging society

By Frances Rylands-Monk

The European Society of Radiology (ESR) is set to welcome the European Society for Hybrid Medical Imaging under its umbrella, in line with efforts to increase training in nuclear medicine. Dr. Katrine Riklund will preside over the new society, and the official launch will take place at ECR 2016.

November 22, 2015

Rubidium PET/CT reveals vascular problems in diabetes patients

By Eric Barnes

Danish researchers have found high rates of microvascular disease using PET/CT with a rubidium radiopharmaceutical in diabetes patients without symptoms of heart disease. The disease was exacerbated in the setting of albuminuria, a common condition in these patients, according to a new study in Diabetologia.

November 15, 2015

Mirada wins contract for 30 U.K. centers

By AuntMinnieEurope.com staff writers

Medical imaging software developer Mirada Medical announced its XD3 Advanced image review and analysis software is being used by Alliance Medical in partnership with 30 National Health Service (NHS) hospital PET/CT departments nationwide.

November 9, 2015

Europe's radiopharma market to reach 1.5B euros by 2020

By AuntMinnieEurope.com staff writers

The European nuclear medicine and radiopharmaceuticals market will be worth 1.5 billion euros by 2020 compared with 1.0 billion euros in 2015, according to a new report by Markets & Markets.

November 8, 2015

Three-pronged glioma therapy shows promise

By Jude Dineley

A combination of x-rays, chemotherapy, and a radiosensitizing drug more than doubled tumor cell death in vitro compared with a radiation-only control, according to Australian research. The combination selectively targets tumor cells and can reduce side effects in patients.

November 4, 2015

RCR releases guidance on hybrid imaging

By AuntMinnieEurope.com staff writers

The U.K. Royal College of Radiologists (RCR) has published a new position statement on the reporting of hybrid imaging studies such as PET/CT, SPECT/CT, and PET/MR.

October 27, 2015

Lightpoint gets CE Mark for molecular imaging device

By AuntMinnieEurope.com staff writers

Luminescence imaging technology developer Lightpoint Medical has obtained CE Mark approval for its LightPath imaging system, an intraoperative molecular imaging device.

October 19, 2015

FDG-PET predicts survival in Parkinsonian syndrome

By Wayne Forrest

FDG-PET strongly predicts overall survival in patients suspected of having early-stage atypical Parkinsonian syndrome, according to a study in the October Journal of Nuclear Medicine. The modality's findings closely matched clinical diagnosis at one-year follow-up.

October 18, 2015

Previous Page

Page 75 of 125

Next Page